ArticleActa pharmaceutica Sinica. B2024

Anti-osteosarcoma trimodal synergistic therapy using NiFe-LDH and MXene nanocomposite for enhanced biocompatibility and efficacy.

Yani Xu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.